tiprankstipranks
Trending News
More News >
Arteris (AIP)
NASDAQ:AIP
US Market

Arteris (AIP) Earnings Dates, Call Summary & Reports

Compare
360 Followers

Earnings Data

Report Date
Apr 30, 2026
After Close (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
-0.07
Last Year’s EPS
-0.09
Same Quarter Last Year
Based on 3 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 12, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call delivered a broadly positive operating and commercial update: strong revenue growth (Q4 +30% YoY), record ACV+royalties (+28% YoY), material royalty momentum (+50% YoY), high gross margins (92%), expanding product adoption (FlexNoC, Ncore) and strategic acquisition (Cycuity) that expands addressable market. Offsetting these positives are persistent GAAP losses, continuing non-GAAP losses (albeit improved), a partially one-time royalty boost in Q4, and near-term drag and margin nuance from Cycuity along with some revenue timing risk from RPO recognition and an equity raise that has not fully executed. On balance, the highlights materially outweigh the lowlights given strong top-line momentum, cash generation, improving non-GAAP metrics, and a credible path to profitability guided for 2026.
Company Guidance
For Q1 2026 Arteris guided ACV plus royalties of $85–89M, revenue of $20.5–21.5M, a non‑GAAP operating loss of $3.5–2.5M, and non‑GAAP free cash flow of −$1.5–+$1.5M; for full‑year 2026 it guided ACV plus royalties to exit at $100–104M, revenue of $89–93M (including approximately $7M from the Cycuity acquisition), a non‑GAAP operating loss of $9–5M (about $1M related to Cycuity), and non‑GAAP free cash flow of +$5–+ $9M, noting that roughly half of the $117M RPO exiting Q4 is expected to convert to 2026 revenue and that most Cycuity revenue will be ratable as the company pursues a path to non‑GAAP operating profitability as early as 2026.
Revenue Growth and Beat
Q4 revenue of $20.1M, up 16% sequentially and 30% year-over-year, beating the top end of guidance; full-year 2025 revenue $70.6M, up 22% YoY.
Record ACV plus Royalties and RPO
Annual contract value plus royalties (ACV+royalties) reached a record $83.6M, up 28% YoY; remaining performance obligations (RPO) ended Q4 at $117.0M, up 32% YoY.
Strong Royalty Momentum
Variable royalties increased ~50% YoY with Q4 setting a new record; number of large six-figure-plus royalty reporters grew to nine (from one five years ago), broadening royalty base.
High Gross Margins and Improving Operating Leverage
Non-GAAP gross margin at 92% in Q4 and for the full year; non-GAAP operating expense growth (14% YoY) was roughly half the rate of revenue growth, delivering an 8 percentage-point year-over-year improvement in non-GAAP operating margin.
Positive Free Cash Flow and Strong Balance Sheet
Ended 2025 with $59.5M in cash/cash equivalents and no financial debt; free cash flow of +$3.0M in Q4 and +$5.3M for the full year, near the top end of guidance.
Strategic Product Adoption and Ecosystem Wins
FlexNoC licensed for over 30 production device deployments; Ncore and other products adopted by large customers (NXP, AMD, Altera, Blaize, Black Sesame); customers shipped over 4 billion chips/chiplets using company IP.
Cycuity Acquisition Expands TAM
Closed acquisition of Cycuity (Jan 14, 2026) to add semiconductor hardware-security assurance products; management expects Cycuity to contribute approximately $7M revenue to 2026 and to open cross-sell opportunities across existing and new customers.

Arteris (AIP) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AIP Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 2026
2026 (Q1)
-0.07 / -
-0.09
Feb 12, 2026
2025 (Q4)
-0.07 / -0.05
-0.150.00% (+0.05)
Nov 04, 2025
2025 (Q3)
-0.09 / -0.09
-0.08-12.50% (>-0.01)
Aug 05, 2025
2025 (Q2)
-0.10 / -0.11
-0.110.00% (0.00)
May 13, 2025
2025 (Q1)
-0.12 / -0.09
-0.1540.00% (+0.06)
Feb 18, 2025
2024 (Q4)
-0.11 / -0.10
-0.1844.44% (+0.08)
Nov 05, 2024
2024 (Q3)
-0.12 / -0.08
-0.1233.33% (+0.04)
Aug 01, 2024
2024 (Q2)
-0.14 / -0.11
-0.1315.38% (+0.02)
May 02, 2024
2024 (Q1)
-0.17 / -0.15
-0.1711.76% (+0.02)
Feb 20, 2024
2023 (Q4)
-0.20 / -0.18
-0.12-50.00% (-0.06)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AIP Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 12, 2026
$14.92$14.62-2.01%
Nov 04, 2025
$12.32$15.53+26.06%
Aug 05, 2025
$13.00$9.88-24.00%
May 13, 2025
$8.35$7.51-10.06%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Arteris (AIP) report earnings?
Arteris (AIP) is schdueled to report earning on Apr 30, 2026, After Close (Confirmed).
    What is Arteris (AIP) earnings time?
    Arteris (AIP) earnings time is at Apr 30, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AIP EPS forecast?
          AIP EPS forecast for the fiscal quarter 2026 (Q1) is -0.07.